Predictive role of executive function in the efficacy of intermittent theta burst stimulation and 10-Hz transcranial magnetic stimulation modalities for treating methamphetamine use disorder

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100046954

Enrollment

Unknown

Registered

2021-06-01

Start date

2019-07-01

Completion date

Unknown

Last updated

2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance addiction

Interventions

3:Repetitive transcranial magnetic stimulation

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Aged 18–49 years; 2. Normal vision and audition; 3. Received no medications during treatment; 4. Used methamphetamine in the past 3 months before being recruited in this study.

Exclusion criteria

Exclusion criteria: 1. Serious physical or neurological illness, a diagnosis of any other psychiatric disorder under DSM-5 criteria (except for nicotine use disorder); 2. Any contraindications to rTMS.

Design outcomes

Primary

Measure	Time frame
behavior rating inventory of executive function;Visual Analogue Scale;	—

Countries

China

Contacts

Public ContactJiao Dongliang

School of Mental Medicine, Bengbu Medical College

jdl3925697@163.com+86 15005527903

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026